Not applicableStudy completedNCT00476229What this trial is testingThymoglobulin and Total Lymphoid Irradiation for Hematologic MalignanciesWho this might be right forLymphomaLeukemia M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729What this trial is testingA Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT03702231What this trial is testingResponse to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)Who this might be right forSafety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more National Heart, Lung, and Blood Institute (NHLBI) 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT01589302What this trial is testingPCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic LeukemiaWho this might be right forProlymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory/Relapsed Chronic Lymphocytic Leukemia Kami Maddocks, MD 154
Large-scale testing (Phase 3)Looking for participantsNCT06943872What this trial is testingInvestigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeOne Medicines 630
Testing effectiveness (Phase 2)Looking for participantsNCT06644183What this trial is testingRoginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemiaRelapsed LeukemiaChronic Lymphocytic Leukemia+2 more Jennifer R. Brown, MD, PhD 64
Testing effectiveness (Phase 2)Study completedNCT00055653What this trial is testingDonor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192237What this trial is testingPhase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic LeukemiaWho this might be right forPhase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00792831What this trial is testingPhase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Italfarmaco 3
Not applicableLooking for participantsNCT06355739What this trial is testingCD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+Who this might be right forB Lymphocytic LeukemiaB Lymphoblastic Lymphoma Zhu Xiaofan 60
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT00002657What this trial is testingSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm SWOG Cancer Research Network 20
Large-scale testing (Phase 3)Study completedNCT00052936What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Very early researchLooking for participantsNCT06636175What this trial is testing64Cu-LLP2A for Imaging Hematologic MalignanciesWho this might be right forMultiple MyelomaLow-Grade LymphomaFollicular Lymphoma+4 more Washington University School of Medicine 42
Early research (Phase 1)Ended earlyNCT03601819What this trial is testingPacritinib in Relapsed/Refractory Lymphoproliferative DisordersWho this might be right forLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more University of Michigan Rogel Cancer Center 4
Early research (Phase 1)Study completedNCT02240719What this trial is testingEverolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more University of California, Davis 20
Not applicableNot Yet RecruitingNCT07337967What this trial is testingReticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative NeoplasmsWho this might be right forB Chronic Lymphocytic Leukemia Huda Ahmed Abdelsabour Abdelwahab 120
Testing effectiveness (Phase 2)Study completedNCT01113632What this trial is testingOfatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma SCRI Development Innovations, LLC 77
Not applicableStudy completedNCT01233921What this trial is testingPalifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more Martin, Paul 6
Early research (Phase 1)Study completedNCT01671904What this trial is testingVenetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Genentech, Inc. 84